645 related articles for article (PubMed ID: 12415256)
1. Cachexia in cancer patients.
Tisdale MJ
Nat Rev Cancer; 2002 Nov; 2(11):862-71. PubMed ID: 12415256
[No Abstract] [Full Text] [Related]
2. Adaptation of the ubiquitin-proteasome proteolytic pathway in cancer cachexia.
Attaix D; Combaret L; Tilignac T; Taillandier D
Mol Biol Rep; 1999 Apr; 26(1-2):77-82. PubMed ID: 10363651
[TBL] [Abstract][Full Text] [Related]
3. Biomedicine. Protein loss in cancer cachexia.
Tisdale MJ
Science; 2000 Sep; 289(5488):2293-4. PubMed ID: 11041796
[No Abstract] [Full Text] [Related]
4. Cancer cachexia: the molecular mechanisms.
Argilés JM; Moore-Carrasco R; Fuster G; Busquets S; López-Soriano FJ
Int J Biochem Cell Biol; 2003 Apr; 35(4):405-9. PubMed ID: 12565701
[TBL] [Abstract][Full Text] [Related]
5. Skeletal muscle metabolism in physiology and in cancer disease.
Giordano A; Calvani M; Petillo O; Carteni' M; Melone MR; Peluso G
J Cell Biochem; 2003 Sep; 90(1):170-86. PubMed ID: 12938166
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of cancer cachexia.
Tisdale MJ
J Support Oncol; 2003; 1(3):159-68. PubMed ID: 15334872
[TBL] [Abstract][Full Text] [Related]
7. Systemic inflammation correlates with increased expression of skeletal muscle ubiquitin but not uncoupling proteins in cancer cachexia.
DeJong CH; Busquets S; Moses AG; Schrauwen P; Ross JA; Argiles JM; Fearon KC
Oncol Rep; 2005 Jul; 14(1):257-63. PubMed ID: 15944798
[TBL] [Abstract][Full Text] [Related]
8. Cytokines and cancer anorexia cachexia syndrome.
Bennani-Baiti N; Davis MP
Am J Hosp Palliat Care; 2008; 25(5):407-11. PubMed ID: 18403577
[TBL] [Abstract][Full Text] [Related]
9. [Systemic and local mechanisms leading to cachexia in cancer].
Grabiec K; Burchert M; Milewska M; Błaszczyk M; Grzelkowska-Kowalczyk K
Postepy Hig Med Dosw (Online); 2013 Dec; 67():1397-409. PubMed ID: 24493689
[TBL] [Abstract][Full Text] [Related]
10. TNF-α and cancer cachexia: Molecular insights and clinical implications.
Patel HJ; Patel BM
Life Sci; 2017 Feb; 170():56-63. PubMed ID: 27919820
[TBL] [Abstract][Full Text] [Related]
11. A new model of cancer cachexia: contribution of the ubiquitin-proteasome pathway.
Lazarus DD; Destree AT; Mazzola LM; McCormack TA; Dick LR; Xu B; Huang JQ; Pierce JW; Read MA; Coggins MB; Solomon V; Goldberg AL; Brand SJ; Elliott PJ
Am J Physiol; 1999 Aug; 277(2):E332-41. PubMed ID: 10444430
[TBL] [Abstract][Full Text] [Related]
12. Biochemical mechanisms of cellular catabolism.
Tisdale MJ
Curr Opin Clin Nutr Metab Care; 2002 Jul; 5(4):401-5. PubMed ID: 12107376
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of lipolysis and muscle protein degradation by EPA in cancer cachexia.
Tisdale MJ
Nutrition; 1996 Jan; 12(1 Suppl):S31-3. PubMed ID: 8850217
[TBL] [Abstract][Full Text] [Related]
14. Molecular and neuroendocrine mechanisms of cancer cachexia.
Mendes MC; Pimentel GD; Costa FO; Carvalheira JB
J Endocrinol; 2015 Sep; 226(3):R29-43. PubMed ID: 26112046
[TBL] [Abstract][Full Text] [Related]
15. Cancer cachexia.
Tisdale MJ
Langenbecks Arch Surg; 2004 Aug; 389(4):299-305. PubMed ID: 15168125
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy inhibits skeletal muscle ubiquitin-proteasome-dependent proteolysis.
Tilignac T; Temparis S; Combaret L; Taillandier D; Pouch MN; Cervek M; Cardenas DM; Le Bricon T; Debiton E; Samuels SE; Madelmont JC; Attaix D
Cancer Res; 2002 May; 62(10):2771-7. PubMed ID: 12019153
[TBL] [Abstract][Full Text] [Related]
17. The 'cancer cachectic factor'.
Tisdale MJ
Support Care Cancer; 2003 Feb; 11(2):73-8. PubMed ID: 12560934
[TBL] [Abstract][Full Text] [Related]
18. Manipulation of the ubiquitin-proteasome pathway in cachexia: pentoxifylline suppresses the activation of 20S and 26S proteasomes in muscles from tumor-bearing rats.
Combaret L; Rallière C; Taillandier D; Tanaka K; Attaix D
Mol Biol Rep; 1999 Apr; 26(1-2):95-101. PubMed ID: 10363654
[TBL] [Abstract][Full Text] [Related]
19. Cancer anorexia and cachexia.
Tisdale MJ
Nutrition; 2001 May; 17(5):438-42. PubMed ID: 11377146
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid.
Whitehouse AS; Smith HJ; Drake JL; Tisdale MJ
Cancer Res; 2001 May; 61(9):3604-9. PubMed ID: 11325828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
